T. Ahlert

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

Volker Schirrmacher, C Haas, R Bonifer et al. · Gene Therapy · 1999 · 153 citations

Medicine, Immunology, Oncology +17

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.

D. Ockert, Volker Schirrmacher, Norman Beck et al. · PubMed · 1996 · 133 citations

Medicine, Immunology, Oncology +17

Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer

Axel Hoos, H. Hepp, Sepp Kaul et al. · International Journal of Cancer · 1998 · 117 citations · Full text

Medicine, Cancer Biology, Oncology +15

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

R. Heicappell, Volker Schirrmacher, Paul von Hoegen et al. · International Journal of Cancer · 1986 · 106 citations

Life Sciences, Immunology, Oncology +16

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.

T. Ahlert, Willi Sauerbrei, G. Bastert et al. · Journal of Clinical Oncology · 1997 · 105 citations

Medicine, Immunology, Oncology +17